2018
DOI: 10.1111/bjh.15620
|View full text |Cite
|
Sign up to set email alerts
|

Dose‐limiting stomatitis associated with ibrutinib therapy: a case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 10 publications
0
1
0
1
Order By: Relevance
“…Ibrutinib may induce mucositis which has been described as aphthous-like lesions. 17
Fig. 13 Stomatitis in a patient treated with targeted therapy; the patient had multiple simultaneous lesions.
…”
Section: Associated Oral Lesionsmentioning
confidence: 99%
“…Ibrutinib may induce mucositis which has been described as aphthous-like lesions. 17
Fig. 13 Stomatitis in a patient treated with targeted therapy; the patient had multiple simultaneous lesions.
…”
Section: Associated Oral Lesionsmentioning
confidence: 99%
“…As consequências dessas alterações no período préenxertia ainda são pouco discutidas. As complicações orais tardias do TCTH são várias, dentre elas DECHc, aumento do risco de cárie dentária e doença periodontal, aumento do risco de neoplasias secundárias como carcinoma espinocelular, osteonecrose secundária a bifosfonatos ou uso de corticóides e lesões orais ocasionadas por terapia alvo são as mais frequentemente descritas (Mahé et al, 2005;Vigarios et al, 2019).…”
Section: -Fase Precoce Do Tcth E a Cavidade Bucalunclassified